Low-Carb Breakfast Aids Glucose Measures With Diabetes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, June 22, 2023 -- A low-carbohydrate (LC) breakfast is associated with improved glucose measures among individuals with type 2 diabetes (T2D), according to a study published online May 29 in the American Journal of Clinical Nutrition.
Barbara F. Oliveira, Ph.D., from University of British Columbia in Kelowna, Canada, and colleagues investigated if an LC breakfast (∼465 kcal: 25 g protein, 8 g carbohydrates, and 37 g fat) could improve glucose control in people with T2D when compared to a low-fat (LF) control breakfast (∼450 kcal: 20 g protein, 56 g carbohydrates, and 15 g fat). The analysis included 121 participants randomly assigned to LC or LF breakfast for three months.
The researchers found that hemoglobin A1C (HbA1c) was reduced (−0.3 percent) after 12 weeks of an LC breakfast. However, the between-group difference in HbA1c was of borderline statistical significance (−0.2; 95 percent confidence interval, −0.4 to 0.0; P = 0.06). In the LC group, self-reported total daily energy (−242 kcal) and carbohydrate (−73 g) intake were lower but the significance of this difference is unclear. Significant differences were seen for mean and maximum glucose, area under the curve, glycemic variability, standard deviation, and time above range in the LC group, while time in the range was significantly higher versus the LF group.
"Advice and guidance to consume a LC breakfast appears to be a simple dietary strategy to reduce overall energy and carbohydrate intake and improve several continuous glucose monitoring variables," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Adherence to Mediterranean Diet Linked to Lower Risk for Mortality
TUESDAY, June 4, 2024 -- Adherence to the Mediterranean diet is associated with a lower risk for all-cause mortality, which is partly explained by multiple cardiometabolic...
Ultraprocessed Food Intake Tied to Chronic Insomnia
TUESDAY, June 4, 2024 -- Consumption of ultraprocessed foods (UPF) is independently tied to chronic insomnia in the general population, according to a study recently published in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.